Ambrx Biopharma Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
3.00
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.13
|
0.00
|
0.13
|
100.00%
|
|
2022-09-30
|
-0.11
|
0.00
|
0.11
|
100.00%
|
|
2022-06-30
|
-0.09
|
-1.33
|
-1.24
|
-1377.78%
|
|
2022-03-31
|
-0.09
|
-0.09
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.07
|
-0.07
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.04
|
-0.09
|
-0.05
|
-112.50%
|
|
2020-12-31
|
0.00
|
-5.72
|
-5.72
|
0.00%
|
|
2020-03-31
|
0.00
|
-0.14
|
-0.14
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-09-30
|
-1.58
|
|
2020-12-31
|
-5.86
|
|
2019-12-31
|
-0.14
|